Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 14 Sep 2009 Additional trial identifier (NCT00974389, CDR0000649021, OSAKA-TRICC0901) identified as reported by ClinicalTrials.gov.
- 11 Sep 2009 New source identified and integrated (ClinicalTrials.gov record no. NCT00974389)
- 17 Aug 2009 New trial record